Rwanda vs Sub-Saharan Africa (IDA & IBRD countries): Access to anti-retroviral drugs, male
Rwanda
95.0%
in 2024
Sub-Saharan Africa (IDA & IBRD countries)
79.8%
in 2024
Rwanda rank
4th
Sub-Saharan Africa (IDA & IBRD countries) rank
7th
Access to anti-retroviral drugs, male over time
- Rwanda
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
Rwanda currently reports 95.0% against 79.8% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 15.2%.
That makes Rwanda's figure about 1.2 times Sub-Saharan Africa (IDA & IBRD countries)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Sub-Saharan Africa (IDA & IBRD countries) ahead.
Rwanda ranks 4th and Sub-Saharan Africa (IDA & IBRD countries) ranks 7th of 141 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.4% | 5.7% | 4.7% | Rwanda |
| 2010s | 60.0% | 42.2% | 17.8% | Rwanda |
| 2020s | 90.0% | 73.2% | 16.8% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Rwanda or Sub-Saharan Africa (IDA & IBRD countries)?
- Rwanda, at 95.0% against 79.8% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Rwanda and Sub-Saharan Africa (IDA & IBRD countries)?
- 15.2%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Sub-Saharan Africa (IDA & IBRD countries)?
- 25 years are reported by both, from 2000 to 2024.
- How do Rwanda and Sub-Saharan Africa (IDA & IBRD countries) rank globally for access to anti-retroviral drugs, male?
- Rwanda ranks 4th and Sub-Saharan Africa (IDA & IBRD countries) ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.